Pfizer's Weight-Loss Data Just Upends Investor Bets
Pfizer is stepping into a high-stakes arena long led by Lilly and Novo Nordisk. This article analyzes what pfizer's w...
Risk tolerance in crypto investing guides how much volatility and drawdown you can endure while pursuing growth.
26,560 articlesPfizer is stepping into a high-stakes arena long led by Lilly and Novo Nordisk. This article analyzes what pfizer's w...
A surprising 90% rally in a little-known healthcare stock has investors asking what comes next. This guide breaks dow...
As ad-tech rotates from pandemic-driven momentum to more measured growth, The Trade Desk faces a pivotal moment. This...
Progressive is more than its ads. This article shows how underwriting profits interact with float income, and why ris...
Dividend-focused investors face a unique puzzle with Boeing: potential for future income vs. exposure to cyclic risk....
Cybersecurity stocks are commanding attention as threats rise and tech spending grows. This July guide breaks down ho...
As Madrigal prepares to report its 2025 earnings, investors weigh pipeline progress, cash runway, and milestones ahea...
Rising electricity costs driven by AI data centers are reshaping the landscape for utility stocks. This deep dive exp...
As the calendar closes on 2025, Ascendis (ASND) faces the final earnings closeout with questions about cash, pipeline...
SpaceX is the darling of space dreams and bold tech bets. This article breaks down what it would take for a public Sp...
Want to decode finance america (foa) earnings? This investor's guide breaks down the numbers, explains what to watch ...
A massive debt issuance reveals where Amazon is headed under Andy Jassy. This article breaks down the implications fo...